The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containingQuillajasaponin components QH-A, QH-C and ISCOPREPTM703
Open Access
- 1 February 2005
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 43 (2) , 269-276
- https://doi.org/10.1016/j.femsim.2004.08.010
Abstract
A successful vaccine against human RSV (HRSV) is likely to induce a Th1 or a balanced Th1/TH2 cytokine response. We tested a panel of HRSV immunostimKeywords
This publication has 25 references indexed in Scilit:
- The ISCOM™ TechnologyPublished by Springer Nature ,2003
- Different respiratory syncytial virus andQuillajasaponin formulations induce murine peritoneal cells to express different proinflammatory cytokine profilesFEMS Immunology & Medical Microbiology, 2001
- Immunomodulation by Iscoms, Immune Stimulating ComplexesMethods, 1999
- IN VIVO AND IN VITRO INDUCTION OF IL-6 BYQUILLAJA SAPONARIAMOLINA TRITERPENOID FORMULATIONSCytokine, 1997
- IMMUNOMODULATION BYQUILLAJA SAPONARIAADJUVANT FORMULATIONS: IN VIVO STIMULATION OF INTERLEUKIN 12 AND ITS EFFECTS ON THE ANTIBODY RESPONSECytokine, 1997
- Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrixVaccine, 1995
- IL6 and the T-cell responseResearch in Immunology, 1992
- Comparison of caprine, human and bovine strains of respiratory syncytial virusArchiv für die gesamte Virusforschung, 1989
- Respiratory syncytial virusArchiv für die gesamte Virusforschung, 1985
- Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped virusesNature, 1984